Choosing a Healthcare Marketing Agency for Medtech Requires 4 Questions Most Founders Never Ask

Key Takeaways

• Most healthcare marketing agencies were built for pharma and hospital systems, the budgets, buyer psychology, and sales cycle in pre-traction medtech are completely different.
• Neil Patel told me directly: "It's too competitive to be a general agency." Focus on a vertical like medtech or get out of the way.
• Stuart Simpson, CEO of THINK Surgical, was blunt: "There's no Playbook anymore." The old agency model built for a one-robot market is gone.
• A medtech specialist understands the VAC, the KOL lifecycle, and the gap between FDA clearance and first reimbursable use. A generalist calls that gap a PR opportunity.
• The 4 questions below cut through the pitch in 20 minutes. If an agency can't answer all four with specific examples, they're building their medtech capability with your budget.
• FDA clearance is the starting line, not the finish line. Your agency should already know that.

A healthcare marketing agency that hasn't stood inside the medtech sales cycle can't build pull-driven demand for your device. Most founders learn this six months after signing the retainer.

How Founders End Up With the Wrong Healthcare Marketing Agency

The agency had a polished deck. They named three health system clients. They used phrases like "integrated campaigns" and "the full patient journey."

You signed.

Six months later, you're reviewing a brand awareness report with no clinical adoption behind it.

This story is common. I've heard it dozens of times across 370 episodes of The State of MedTech. The mistake isn't hiring an agency. It's hiring one using the wrong selection criteria.

Generalist healthcare marketing services cover the category at a conceptual level. They understand regulated messaging, patient journey frameworks, and compliance review. But the medtech sales cycle operates in a completely different layer.

The buyer isn't a consumer. It isn't a prescriber. It's a VAC. It's a committee. It's a clinical champion who has to go to bat for your device inside the health system.

Pull-driven demand in medtech doesn't come from reach. It comes from clinical conviction that travels sideways through the peer network, upward through the KOL layer, and forward through procurement. A healthcare marketing agency that doesn't understand this architecture can't engineer it.

The 4 Questions That Reveal Whether an Agency Knows Medtech Buyers

These four questions cut to what matters in under 20 minutes.

Question 1: Have you built a clinical sell-in motion for a device that required VAC approval?

Not a digital ad campaign. Not a content program. A market engineering motion for a device that couldn't close until a clinical champion built internal consensus across a value analysis committee.

If they don't know what a VAC is, that's your answer.

Question 2: What does a real KOL strategy look like over the first 18 months?

Real KOL architecture in medtech isn't a speaker bureau or an ambassador program. It's an 18-month relationship-building process that starts before launch. Agencies that treat KOL work as a campaign deliverable have only seen it from the outside.

Question 3: Have you worked a device from clearance through the reimbursement cycle?

FDA clearance is the starting line. Most medtech startups hit the traction gap right here, in the space between "cleared" and "paid for." A specialist who has lived through a CPT code campaign understands what you're walking into. A generalist will call it a communications opportunity.

Question 4: How do you differentiate category conviction from brand awareness?

This one draws the line. Generalists optimize for awareness. Specialists build market narrative. They position the device as the answer to a clinical problem the market hasn't yet named. If the answer involves "multi-channel healthcare marketing services" or "integrated awareness," you're talking to a generalist.

If an agency can't answer all four with specific examples, they're figuring out medtech with your budget.

Why Generalist Healthcare Marketing Agencies Default to the Pharma Playbook

Most agencies in the healthcare marketing space built their capabilities during the era of pharma and hospital system growth.

That era had money. Pharmaceutical DTC campaigns run into nine figures. Hospital systems compete on regional brand recognition. The playbook for that world is real and it works.

But medtech startups don't have DTC budgets, broad consumer audiences, or the runway for a multi-year category education campaign.

I spoke with Neil Patel about agency strategy on an episode covering digital marketing approaches for medtech companies. He gave a direct answer on what any agency needs to do to compete:

"Focus on a vertical like Medtech or e-commerce. The vertical could just be I'm only doing SEO or I'm only doing paid ads, but ideally I'm only doing SEO or paid ads for one industry. It's too competitive to be a general agency."

That's the market from the agency side. From the founder's side, the risk is signing with a generalist before they've done the vertical work.

Stuart Simpson, CEO of THINK Surgical, said it from the commercialization side when we spoke on an episode about building a differentiated commercialization strategy for robotic surgery:

"There's no Playbook anymore. That Playbook is like a decade old and worked when there was only one robotics company in the world. That Playbook doesn't work anymore."

Simpson wasn't just talking about sales. He was talking about how entire companies approach market entry. And the agencies that built their playbooks for a one-robot, one-market world are still running that decade-old model.

What a Medtech Marketing Specialist Does Differently

The functional difference between a generalist and a specialist isn't in the tactics. Both run content, paid media, and conference programs.

The difference is in the brief.

A medtech specialist briefs their work around the clinical champion. They ask: who is the person inside the health system who will take a reputational risk on your device?

Then they build the marketing motion around arming that person, giving them the clinical evidence, peer validation, and economic argument to make the case internally.

A generalist briefs around the awareness funnel. Reach more people. Convert more visitors.

For a pre-traction medtech company, that approach doesn't move procurement. The problem isn't awareness. The clinical champion who already knows about your device doesn't yet have what they need to win the internal fight.

That's what a specialist understands. And it's exactly what the 4 questions above test for.

For a deeper view of the commercial strategy behind this, the medical device go-to-market strategy guide covers the full motion. And the category design in medtech guide explains why category design is the foundation that has to exist before any agency can do useful work.

What This Means for Medtech Founders

In my experience working with medtech founders, the agency decision gets made too fast and reversed too late.

By the time you realize the fit is wrong, you've spent six months, a full retainer, and the access window you had with two key physician champions. Those physicians are now fielding calls from your competitors.

The 4-question framework above isn't designed to find the best agency in the world. It's designed to immediately disqualify firms that haven't done the work. Most can't answer all four with specific examples. That tells you everything.

Here's how this connects to the broader picture. The pillar post on hiring a healthcare marketing agency covers why you shouldn't hire one before defining your category. This post covers what to look for when you're ready. Two gates in the same sequence.

The last thing I'd add: ask any healthcare marketing agency you're evaluating for one case study from a pre-revenue medtech company they took from clearance to first reimbursable use. One. If they don't have it, they're building that capability with your budget.

Frequently Asked Questions

What does a healthcare marketing agency do for medical device companies?

A healthcare marketing agency helps medical device companies build market presence and support commercial launch. In medtech specifically, this includes KOL strategy, clinical content, conference presence, and digital channels targeting physicians and health system buyers.

A specialist firm also supports category design, positioning the device as the answer to a clinical problem the market hasn't yet named.

How do you choose between a generalist healthcare marketing agency and a medtech specialist?

Use four diagnostic questions: Have they built a VAC-level clinical sell-in motion? Can they describe a real 18-month KOL architecture? Have they worked a device through a reimbursement cycle?

Do they distinguish between category conviction and brand awareness? A generalist can speak to healthcare marketing services broadly. A specialist answers all four with specific examples.

When should a medtech startup hire a healthcare marketing agency?

The right time is after defining your minimum viable category and identifying your clinical champion profile. Hiring before you know who your buyer is gives an agency nothing specific to work from. They'll default to awareness activity. The category design work comes first. The agency amplifies it.

How much does a healthcare marketing agency cost for a medtech company?

Specialist medtech agencies typically run $8,000 to $25,000 per month in retainer, depending on scope. Project-based work ranges from $15,000 to $75,000. Generalist healthcare agencies often quote lower, but the risk isn't the price.

It's the mismatch between their playbook and your sales cycle. A $5,000 per month generalist retainer that produces no clinical traction costs more than a $15,000 specialist that engineers it.

Listen to the Full Conversations

These episodes cover healthcare marketing agency strategy, medtech commercialization, and the agency selection process in depth.

• Neil Patel on digital marketing strategy and agency specialization for medtech companies
• Stuart Simpson, CEO of THINK Surgical, on commercialization strategy for robotic surgery

Subscribe to The State of MedTech wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.

He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.